| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IT | Common Stock | +Options Exercise | $655,843 | +6,620 | +35.78% | $99.07 | 25,121 | Aug 21, 2023 | Direct | F1 |
| transaction | IT | Common Stock | -Disposed to Issuer | -$655,917 | -1,975 | -7.86% | $332.11 | 23,146 | Aug 21, 2023 | Direct | F2 |
| transaction | IT | Common Stock | -Tax liability | -$714,701 | -2,152 | -9.3% | $332.11 | 20,994 | Aug 21, 2023 | Direct | F3 |
| transaction | IT | Common Stock | +Options Exercise | $1,767,374 | +15,468 | +73.68% | $114.26 | 36,462 | Aug 21, 2023 | Direct | F1 |
| transaction | IT | Common Stock | -Disposed to Issuer | -$1,767,489 | -5,322 | -14.6% | $332.11 | 31,140 | Aug 21, 2023 | Direct | F2 |
| transaction | IT | Common Stock | -Tax liability | -$1,561,249 | -4,701 | -15.1% | $332.11 | 26,439 | Aug 21, 2023 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IT | Stock Appreciation Rights | -Options Exercise | $0 | -6,620 | -100% | $0.00 | 0 | Aug 21, 2023 | Common Stock | 6,620 | $99.07 | Direct | F4 |
| transaction | IT | Stock Appreciation Rights | -Options Exercise | $0 | -15,468 | -100% | $0.00 | 0 | Aug 21, 2023 | Common Stock | 15,468 | $114.26 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Represents shares acquired upon exercise of SARs. |
| F2 | Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs. |
| F3 | Represents shares withheld for the payment of applicable income and payroll withholding taxes. |
| F4 | These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 6, 2018 and are fully exercisable. |
| F5 | These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 8, 2019 and are fully exercisable. |